tetrabenazine has been researched along with Depression in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (40.54) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (8.11) | 29.6817 |
| 2010's | 16 (43.24) | 24.3611 |
| 2020's | 3 (8.11) | 2.80 |
| Authors | Studies |
|---|---|
| Depoortere, R; Jastrzębska-Więsek, M; Kołaczkowski, M; Newman-Tancredi, A; Varney, MA; Wesołowska, A | 1 |
| Gürağaç Dereli, FT; Ilhan, M; Küpeli Akkol, E | 2 |
| Asar, S; Correa, M; Murray, F; Presby, RE; Rotolo, RA; Salamone, JD; Tracy, O; Yang, JH | 1 |
| Bogner, RH; Collins, S; Correa, M; Gorka, D; Manchanda, A; Mistry, A; Qian, E; Salamone, JD; Yohn, SE | 1 |
| Abler, V; Claassen, DO; DiBonaventura, M; Gandhi, SK; Iyer, RG; Shah-Manek, B; Sung, VW | 1 |
| Chabal, CC; Kamholz, JA; Killoran, A; Moser, DJ; Nopoulos, PC; Schultz, JL | 1 |
| Aziz, NA | 1 |
| Schultz, JL | 1 |
| Macleod, M; Munafò, M; Sampaio, C; Wagenmakers, EJ; Ware, JJ | 1 |
| Kamholz, JA; Killoran, A; Moser, DJ; Nopoulos, PC; Schultz, JL | 1 |
| Shahani, L | 1 |
| Baqi, Y; Correa, M; Freeland, C; Hart, EE; López-Cruz, L; Müller, CE; Nunes, EJ; Randall, PA; Salamone, JD; Yohn, SE | 1 |
| Agarwal, PA; Appel-Cresswell, S; Dinelle, K; Farrer, MJ; Felicio, AC; Heffernan, N; McKenzie, J; Road, JD; Schulzer, M; Sossi, V; Stoessl, AJ; Wszolek, ZK | 1 |
| Baqi, Y; Correa, M; Khan, B; Lee, CA; Makriyannis, A; Müller, CE; Nowak, V; Nunes, EJ; Pandit, S; Randall, PA; Salamone, JD; Shah, P; Vemuri, VK; Yohn, SE | 1 |
| Anderson, KE; Beck, CA; Biglan, KM; Brocht, AF; Darwin, KC; Dorsey, ER; Nichols, PE; Shoulson, I; Singh, S | 1 |
| Margolis, RL | 1 |
| Guay, DR | 1 |
| Franch, O; Kurtis, MM | 1 |
| Rehavi, M; Schwartz, K; Weizman, A; Yadid, G | 1 |
| POELDINGER, W | 1 |
| ADLER, MW | 1 |
| Bonelli, RM; Hofmann, P | 1 |
| Battegay, R; Kahr, H; Pöldinger, W | 1 |
| Nagayama, H; Tachiki, KH; Takahashi, R; Tateishi, T; Yoshida, H | 1 |
| Glotzbach, RK; Irwin, GH; Kent, TA; Preskorn, SH; Solnick, JV | 1 |
| Kido, A; Nagayama, H; Nakamura, E; Nishiwaki, K; Tachiki, KH; Takagi, A; Takahashi, R; Tateishi, T | 1 |
| Baizman, ER; Ezrin, AM; Ferrari, RA; Luttinger, D | 1 |
| Soutar, CA | 1 |
| Heathfield, KW; Roberts, AH; Swash, M; Zakko, H | 1 |
| McLellan, DL | 1 |
| Kido, A; Morita, T; Nagayama, H; Takahashi, R | 1 |
| Durell, J; Kopin, IJ; Schanberg, SM; Schildkraut, JJ | 1 |
| Harmon, JB; Lynes, TE; Marvel, JP; Smith, DH; Stump, JM; Vernier, VG | 1 |
| Avrutskii, GIa; Mashkovskii, MD; Polezhaeva, AI; Smulevich, AB; Vertozgadova, OP | 1 |
| Benesová, O; Náhunek, K | 1 |
3 review(s) available for tetrabenazine and Depression
| Article | Year |
|---|---|
Tetrabenazine (Xenazine) for Huntington's chorea.
Topics: Animals; Controlled Clinical Trials as Topic; Depression; Humans; Huntington Disease; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2009 |
Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Cytochrome P-450 CYP2D6; Depression; Dopamine; Drug Interactions; Genotype; Humans; Huntington Disease; Hyperkinesis; Middle Aged; Movement Disorders; Neuroleptic Malignant Syndrome; Parkinson Disease, Secondary; Quinolizines; Reserpine; Serotonin; Tetrabenazine; Vesicular Monoamine Transport Proteins; Young Adult | 2010 |
A systematic review of the treatment studies in Huntington's disease since 1990.
Topics: Amantadine; Antipsychotic Agents; Chorea; Depression; Humans; Huntington Disease; Neuroprotective Agents; Riluzole; Sexual Dysfunctions, Psychological; Tetrabenazine | 2007 |
2 trial(s) available for tetrabenazine and Depression
| Article | Year |
|---|---|
Affective disorders and norepinephrine pharmacology.
Topics: Animals; Behavior; Behavior, Animal; Body Temperature; Brain; Brain Chemistry; Chlorpromazine; Clinical Trials as Topic; Cocaine; Depression; Emotions; Female; Humans; Hypothermia, Induced; Imipramine; Lithium; Male; Methyltyrosines; Middle Aged; Monoamine Oxidase Inhibitors; Norepinephrine; Normetanephrine; Placebos; Rats; Reserpine; Tetrabenazine; Vanilmandelic Acid | 1969 |
Correlation between the experimental data from animal studies and therapetical effects of antidepressant drugs.
Topics: Animals; Antidepressive Agents; Depression; Electroencephalography; Female; Humans; Male; Nicotine; Norepinephrine; Physostigmine; Placebos; Rabbits; Reserpine; Tetrabenazine; Tremorine | 1971 |
32 other study(ies) available for tetrabenazine and Depression
| Article | Year |
|---|---|
The selective 5-HT 1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Buspirone; Catalepsy; Depression; Huntington Disease; Parkinsonian Disorders; Piperidines; Pyridines; Rats; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Tetrabenazine | 2022 |
Identification of the main active antidepressant constituents in a traditional Turkish medicinal plant, Centaurea kurdica Reichardt.
Topics: Animals; Antidepressive Agents; Centaurea; Depression; Flowers; Hindlimb Suspension; Male; Medicine, Traditional; Methanol; Mice; Mice, Inbred BALB C; Phytotherapy; Plant Components, Aerial; Plant Extracts; Plant Leaves; Plants, Medicinal; Quercetin; Tetrabenazine | 2020 |
The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology.
Topics: Animals; Choice Behavior; Conditioning, Operant; Depression; Dopamine Plasma Membrane Transport Proteins; Feeding Behavior; Interleukin-1beta; Male; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reward; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2021 |
Oral Ingestion and Intraventricular Injection of Curcumin Attenuates the Effort-Related Effects of the VMAT-2 Inhibitor Tetrabenazine: Implications for Motivational Symptoms of Depression.
Topics: Administration, Oral; Animals; Choice Behavior; Curcuma; Curcumin; Depression; Feeding Behavior; Injections, Intraventricular; Male; Molecular Structure; Motivation; Rats; Rats, Sprague-Dawley; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2017 |
Physician perceptions of pharmacologic treatment options for chorea associated with Huntington disease in the United States.
Topics: Activities of Daily Living; Adult; Aged; Chorea; Cross-Sectional Studies; Depression; Female; Humans; Huntington Disease; Male; Middle Aged; Perception; Physicians; Quality of Life; Surveys and Questionnaires; Tetrabenazine; United States | 2018 |
Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Depression; Female; Humans; Huntington Disease; Longitudinal Studies; Male; Middle Aged; Suicidal Ideation; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2018 |
Discovery of new antidepressant agents: In vivo study on Anthemis wiedemanniana Fisch. & Mey.
Topics: Adrenergic Uptake Inhibitors; Animals; Anthemis; Antidepressive Agents; Behavior, Animal; Depression; Female; Flowers; Hindlimb Suspension; Hypothermia; Locomotion; Male; Mice, Inbred BALB C; Plant Extracts; Tetrabenazine | 2018 |
Reader response: Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
Topics: Depression; Depressive Disorder; Humans; Huntington Disease; Suicide; Tetrabenazine | 2019 |
Author response: Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
Topics: Depression; Depressive Disorder; Humans; Huntington Disease; Suicide; Tetrabenazine | 2019 |
Reader response: Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
Topics: Depression; Depressive Disorder; Humans; Huntington Disease; Suicide; Tetrabenazine | 2019 |
Author response: Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
Topics: Depression; Depressive Disorder; Humans; Huntington Disease; Suicide; Tetrabenazine | 2019 |
Tetrabenazine and suicidal ideation.
Topics: Adrenergic Uptake Inhibitors; Depression; Female; Humans; Huntington Disease; Middle Aged; Suicidal Ideation; Tetrabenazine | 2013 |
Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.
Topics: Adenosine A2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Bupropion; Conditioning, Operant; Depression; Disease Models, Animal; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Enkephalins; Feeding Behavior; Immunohistochemistry; Male; Microdialysis; Motivation; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Substance P; Tetrabenazine; Vesicular Monoamine Transport Proteins; Xanthines | 2013 |
In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriers.
Topics: Adult; Aniline Compounds; Corpus Striatum; Depression; Dopamine; Dynactin Complex; Fluorine Radioisotopes; Humans; Hypoventilation; Microtubule-Associated Proteins; Middle Aged; Mutation; Parkinsonian Disorders; Positron-Emission Tomography; Raclopride; Serotonin; Sulfides; Tetrabenazine; Tomography, Emission-Computed | 2014 |
The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.
Topics: Animals; Antidepressive Agents; Benzazepines; Benzophenones; Bupropion; Cannabinoid Receptor Antagonists; Choice Behavior; Depression; Dopamine Antagonists; Drug Evaluation, Preclinical; Feeding Behavior; Male; Nitrophenols; Pyrazoles; Rats, Sprague-Dawley; Salicylamides; Selegiline; Tetrabenazine; Tolcapone; Vesicular Monoamine Transport Proteins; Xanthines | 2014 |
Depressed mood and suicidality in individuals exposed to tetrabenazine in a large Huntington disease observational study.
Topics: Adrenergic Uptake Inhibitors; Adult; Depression; Female; Humans; Huntington Disease; Male; Middle Aged; Suicidal Ideation; Tetrabenazine | 2013 |
Tetrabenazine, depression and suicide: good news.
Topics: Adrenergic Uptake Inhibitors; Depression; Humans; Huntington Disease; Suicide; Tetrabenazine | 2014 |
Tardive syndrome and Parkinson's disease responsive to concomitant tetrabenazine and levodopa therapy.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Depression; Female; Flupenthixol; Humans; Levodopa; Movement Disorders; Parkinson Disease; Tetrabenazine | 2011 |
Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression.
Topics: Animals; Depression; Disease Models, Animal; Limbic System; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neuropeptides; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2003 |
COMBINED ADMINISTRATION OF DESIPRAMINE AND RESERPINE OR TETRABENAZINE IN DEPRESSIVE PATIENTS.
Topics: Antidepressive Agents; Depression; Depressive Disorder; Desipramine; Humans; Imipramine; Reserpine; Tetrabenazine | 1963 |
ENHANCED DEPRESSANT EFFECT OF TETRABENAZINE AFTER REPEATED ADMINISTRATION.
Topics: Depression; Depressive Disorder; Movement; Pharmacology; Rats; Research; Tetrabenazine | 1964 |
[Psychopathological complications in antidepressant medication].
Topics: Amitriptyline; Animals; Antidepressive Agents; Blood Pressure; Delirium; Depression; Desipramine; Dogs; Guinea Pigs; Humans; Imipramine; Mice; Movement; Rats; Tetrabenazine | 1966 |
Serotonin metabolism of animal model of depression.
Topics: Animals; Behavior, Animal; Brain; Conditioning, Psychological; Depression; Disease Models, Animal; Dopamine; Humans; Hydroxyindoleacetic Acid; Male; Motor Activity; Movement; Norepinephrine; Rats; Serotonin; Tetrabenazine | 1981 |
Cerebromicrocirculatory defects in animal model of depression.
Topics: Amitriptyline; Animals; Brain; Carbon Dioxide; Cerebrovascular Circulation; Depression; Disease Models, Animal; Dopamine; Humans; Male; Microcirculation; Norepinephrine; Rats; Rats, Inbred Strains; Tetrabenazine | 1984 |
Animal model of depression. III. Mechanism of action of tetrabenazine.
Topics: 5-Hydroxytryptophan; Animals; Brain; Brain Chemistry; Depression; Disease Models, Animal; Dopamine; Drug Synergism; Fenclonine; Humans; Hydroxyindoleacetic Acid; Male; Motor Activity; Norepinephrine; Rats; Serotonin; Serotonin Antagonists; Tetrabenazine | 1978 |
Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models.
Topics: Animals; Antidepressive Agents; Biological Transport; Blepharoptosis; Brain; Depression; Disease Models, Animal; Dogs; Dopamine; Imipramine; Mice; Monoamine Oxidase Inhibitors; Motor Activity; Norepinephrine; Purkinje Cells; Pyrazoles; Rats; Reserpine; Serotonin; Synaptosomes; Tetrabenazine | 1987 |
Tetrabenazine for Huntington's chorea.
Topics: Depression; Humans; Huntington Disease; Male; Middle Aged; Tetrabenazine | 1970 |
Treatment of involuntary movement disorders with tetrabenazine.
Topics: Adolescent; Adult; Aged; Amantadine; Child; Depression; Dystonia Musculorum Deformans; Evaluation Studies as Topic; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Sleep Initiation and Maintenance Disorders; Tetrabenazine; Torticollis | 1972 |
The suppression of involuntary movements with tetrabenazine.
Topics: Adolescent; Adult; Aged; Ataxia; Athetosis; Depression; Diencephalon; Evaluation Studies as Topic; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Tetrabenazine; Time Factors; Tremor | 1972 |
An animal model of depression.
Topics: Acoustic Stimulation; Animals; Behavior, Animal; Conditioning, Classical; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Imipramine; Injections, Intraperitoneal; Male; Motor Activity; Rats; Tetrabenazine | 1974 |
The toxicologic and pharmacologic properties of amantadine hydrochloride.
Topics: Abnormalities, Drug-Induced; Acetylcholine; Amantadine; Analgesia; Animals; Arrhythmias, Cardiac; Blood Chemical Analysis; Blood Pressure; Central Nervous System; Depression; Dextroamphetamine; Dogs; Drug Synergism; Electrocardiography; Female; Guinea Pigs; Haplorhini; Heart Rate; Histamine; Horses; Humans; Imipramine; Injections, Intraperitoneal; Injections, Intravenous; Male; Mice; Motor Activity; Nicotine; Norepinephrine; Phenethylamines; Rabbits; Rats; Reproduction; Tetrabenazine; Tritium | 1969 |
[The pharmacologic properties and therapeutic effectiveness of the new antidepressant preparation Azaphen].
Topics: Adult; Aged; Amphetamine; Animals; Antidepressive Agents; Bipolar Disorder; Cats; Depression; Depressive Disorder, Major; Dogs; Drug Synergism; Humans; Male; Mice; Middle Aged; Neurocognitive Disorders; Rats; Reserpine; Schizophrenia; Tetrabenazine | 1969 |